A study of individuals with alcohol use disorder in France found that the negative impact of problematic alcohol use on quality of life is greater in those with attention-deficit/hyperactivity disorder (ADHD) than in those without the condition. The adverse effects on quality of life appear to be amplified by dysfunctional efforts to manage the intense…

Increased sleep difficulties in patients with obsessive-compulsive spectrum disorders (OCSDs), chronic tic disorders (CTDs), and attention-deficit/hyperactivity disorder (ADHD) are likely due to disruptions in the cortico-striatal-thalamo-cortical (CSTC) pathway, according to a literature review published in the Harvard Review of Psychiatry.

Newborn babies with a vitamin D deficiency have a higher chance of later developing mental disorders such as ADHD, schizophrenia and autism, a major study involving The University of Queensland has found. In the largest population study of its kind, researchers examined vitamin D status of 71,793 people, many of whom had a mental health…

Roughly 11% of children and 6% of adults in the U.S are currently diagnosed with ADHD—rates that are significantly higher than those reported in most other countries.

Key Takeaways: There was no evidence to support a causal relationship between stimulant prescription and psychotic experiences in children, ages 9-14 years, treated for attention deficit-hyperactivity disorder. In unweighted analyses, stimulant prescription was associated with subsequent psychotic experiences; however, the reverse was also true in that baseline psychotic experiences predicted subsequent stimulant treatment. When applying…

Key points: The disclosure dilemma means wrestling with whether or not to hide a maskable stigmatized identity. Disclosure isn’t all or nothing—there’s a wide continuum of ways to share. A decisional matrix is one tool that can bring clarity. Those struggling with whether to disclose are not alone—millions are navigating this same decision.

Key Takeaways: Medicaid unwinding led to significant disruptions in chronic medication therapy for young adults, particularly in states with high enrollment losses. The study utilized a difference-in-differences analysis of the IQVIA Longitudinal Prescription Database to assess prescription continuity. States with higher Medicaid enrollment losses saw greater reductions in active prescriptions and increased cash-pay prescriptions. The…

Collaboration in sleep medicine can optimize treatment for conditions like narcolepsy, ADHD, and insomnia.

Summary: One of the first studies in this area to use clinical-level diagnoses reveals a range of differences between young people with and without mental health conditions when it comes to social media — from changes in mood to time spent on sites.

A new study led by the University of Southampton has found that the race and ethnicity of participants in clinical trials of medications for mental health and neurodevelopmental conditions often go unrecorded. In the first comprehensive quantitative review of its kind, an international team of researchers found that just four in ten clinical trials (39%)…

In this conversation, we dive into Pathological Demand Avoidance (PDA)—what it really means, why it’s often misunderstood, and how we can better support kids and adults who experience it. Joining us are Diane Gould, LCSW, founder and executive director of PDA North America; Jessica Richards, MS, MSW, LCSW, licensed psychotherapist; Molly Williams, M.S.W., A.C.S.W., a…

This critical analysis of recent ADHD coverage challenges misconceptions about treatment, emphasizing the need for a comprehensive approach to mental health.